Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma

202151 citationsJournal Articlegold Open Access

Authors

Kazufumi Kobayashi · Chiba University Hospital

Sadahisa Ogasawara · Chiba University

Aya Takahashi · Kyoto Prefectural University of Medicine

Yuya Seko · Kyoto Prefectural University of Medicine

Hidemi Unozawa · Chiba University

Rui Sato · Shizuoka Cancer Center

Shunji Watanabe ·

Abstract

The availability of multiple MTAs had steadily improved the prognosis of patients with advanced HCC patients, particularly advanced-stage HCC patients.

Topics & Keywords

Hepatocellular Carcinoma Treatment and Prognosis Cancer Mechanisms and Therapy Cholangiocarcinoma and Gallbladder Cancer Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Liver Cancer

Volume 11, Issue 1, pp. 48-60

DOI: 10.1159/000519868

Field-Weighted Citation Impact: 5.56